DistillerSR

DistillerSR

AI systematic review platform for regulated evidence workflows

Officially listed
English
Paid
AI文献助手
0favorites
5views
Promote this tool
DistillerSR screenshot

Tool details

DistillerSR is a systematic review and evidence management platform from DistillerSR Inc. of Canada. Its selling point is not smarter AI but an auditable chain that pins every suggestion to a specific person and time.

Core capabilities

  • AI Re-Rank: trains continuously on each reviewer's round-by-round include/exclude decisions and re-ranks the literature; at the 95% recall point it cuts screening burden by a median 47.1%
  • Self-trained AI Classifiers: classifiers trained on project data act as a second reviewer and for pre-screening; a 2019 study showed the underlying model was Naive Bayes (87.9%), while SVM reached only 47.6%
  • GenAI layer: Smart Screening processes 100,000 abstracts in a single run with no pre-training, and Smart Evidence Extraction traces every point back to the source text
  • Smart Chat: launching 2026-10; the LLM reads only the customer's own evidence library and never reaches the open web; included in every edition
  • Rules layer: deduplication, forms, RoB, PRISMA, audit logs and LitConnect are not models; add-on modules include CuratorCR, Classifier Manager and the API

Where it fits CER/PER/SOTA for devices and IVDs, PMS/PSUR, HEOR/HTA and pharmacovigilance in pharma, guideline development, and large-sample academic reviews are the best fit. If you only want an AI to read PDFs and answer questions, or you write ordinary reviews alone, it is over-provisioned.

Differentiation Covidence leans toward academic workflows, Rayyan is free but lightweight, and Elicit is strongest at extraction. The difference is audit defensibility: review intensity can be dialed from dual reviewer to fully automated, and SOC 2 Type II, Part 11, EU Annex 11, NIST AI RMF and GDPR are all documented.

Editorial assessment Validation stops at the old 2019–2020 generation: DistillerAI alone reaches only 14% sensitivity and human-machine agreement is κ=0.85; SEE and Smart Screening have no published accuracy figures, and the LLM vendor is undisclosed. The Philips 74%/70% figures come from a 4-person pilot's own account, and the Stryker 70% is a customer estimate whose attribution is data reuse. Data residency is AWS us-east-1 only, which still makes it worth adopting for regulated teams.

Pricing

Subscription$19.95/month (Student tier, 3 users / 1 project)
Student
$19.95/month

3 users / 1 project, self-serve subscription, includes AI Re-Rank and AI review of exclusion decisions

Faculty
$94/month (billed annually)

1 user / 5 projects

Research Project
$194/month (billed annually)

1 faculty member + 4 students / 5 projects, includes LitConnect

Departmental
Custom quote

20–45 projects, includes CuratorCR data reuse and multiple administrators

Institutional
Custom quote

80–150 projects, includes SSO, AI Classifiers and the API

Corporate & Government
Custom quote

This page of the official site carries only a lead form, so pricing requires submitting the form

Additional notes

The corporate and government tiers are quote-only with no figures published on the official site; there is no free tier and no self-serve trial, and the official FAQ confirms the free student edition has been withdrawn. Product data residency is AWS us-east-1 only.

FAQ

An AI systematic review and evidence management platform for regulated evidence workflows, covering independent dual screening, data extraction, RoB, PRISMA and audit logs. It targets regulatory uses such as CER/PER, HEOR/HTA and pharmacovigilance, not general-purpose document Q&A.

User reviews

User Reviews

No reviews yet

No one has reviewed this tool yet